Evidence map›Paper›PMID 40794948›Full record

ArticleBriefings in bioinformatics2025

On the impact of local protein structure features on prediction of major histocompatibility complex class I and II antigen presentation.

Yat-Tsai Richie Wan, Morten Nielsen

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yat-Tsai Richie WanDepartment of Health Technology, Technical University of Denmark, Kemitorvet, B204, Kgs. Lyngby, DK 28002, Denmark.ORCID 0000-0003-0814-0289
Morten NielsenDepartment of Health Technology, Technical University of Denmark, Kemitorvet, B204, Kgs. Lyngby, DK 28002, Denmark.ORCID 0000-0001-7885-4311

Funding

IMMUNE EPITOPE AND ANALYSIS PROGRAM: Transplantation of organs, tissues and cells 75N93019C00001 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SETTE, ALESSANDRO · 2019 to 2025
$23.1M
THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCEU24CA248138 · NCI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI PETERS, BJOERN, SETTE, ALESSANDRO · 2021 to 2025
$4.6M
NCI NIH HHS U24 CA248138NIAID NIH HHS 75N93019C00001
6 · The paper itself

Abstract

Antigen presentation by major histocompatibility complex (MHC) molecules is a complex pathway essential for T cell-mediated immunity. The pathway involves unfolding and processing of the antigen protein structure, yet limited work has been made evaluating the potential influence of local protein structure on the prediction of antigen processing and presentation. Here, we investigated this by integrating local structural features-disorder score, relative surface accessibility, and the probabilities of α-helix, β-sheet, and coil-into an NNAlign-based framework for predicting MHC class I and HLA-DR antigen presentation. Large-scale eluted ligand datasets were used to train and validate our models, demonstrating that for MHC class I, the addition of structural features yielded marginal, nonsignificant improvements in performance. In contrast, for HLA-DR ligands, models incorporating positional structural information showed a significant yet limited performance boost. Post-hoc analysis revealed no clear amino acid enrichment patterns associated with structural propensities. Rather the HLA-specific gain in performance was found to be linked to the number of positive instances seen in training. Stratification by cellular localisation indicated that peptides from endolysosomal proteins benefited more from structural integration than those from cytosolic sources. Our comprehensive benchmark shows that incorporating local protein structural features improves epitope prediction for MHC class II ligands.

Indexed as

Antigen PresentationHistocompatibility Antigens Class IHistocompatibility Antigens Class IIComputational BiologyHLA-DR AntigensHumansLigandsProtein ConformationHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA-DR AntigensLigandsantigen presentation predictiondeep learningMHC binding predictionstructural features

Identifiers

PMID40794948
PMCPMC12342390

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.